Clinical Trial Update: Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating the safety and potential efficacy of RM-004 cell therapy for Alpha-thalassemia with Hemoglobin H disease due to the Constant S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-thalassemia
• Hemoglobin Disease
• Hemoglobinopathy

Drugs mentioned

• RM-004 cells (RM-004 cells)

Snippet

Sponsor: The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army | Conditions: Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies | EARLY_Phase 1 | Status: RECRUITING